Mara Antonoff, Associate Professor of Thoracic and Cardiovascular Surgery at MD Anderson Cancer Center, shared a post on X:
“Dr Jonathan Spicer at AATSHQ itsos2025 shares NeoADAURA MRD data as an encore to his WCLC25 presentation.
He points out the potential utility of MRD to complement MPR and support the use of neoadjuvant osimertinib in patients with resectable EGFRm stage I-III NSCLC.”
More posts featuring M. Antonoff.
